| Mechanisms of immunotherapy resistance: lessons from glioblastoma CM Jackson, J Choi, M Lim Nature immunology 20 (9), 1100-1109, 2019 | 500 | 2019 |
| Carboxylated branched poly (β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing Y Rui, DR Wilson, J Choi, M Varanasi, K Sanders, J Karlsson, M Lim, ... Science advances 5 (12), eaay3255, 2019 | 141 | 2019 |
| A characterization of dendritic cells and their role in immunotherapy in glioblastoma: from preclinical studies to clinical trials S Srivastava, C Jackson, T Kim, J Choi, M Lim Cancers 11 (4), 537, 2019 | 97 | 2019 |
| ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma L Tong, J Li, Q Li, X Wang, R Medikonda, T Zhao, T Li, H Ma, L Yi, P Liu, ... Theranostics 10 (13), 5943, 2020 | 89 | 2020 |
| Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system R Maxwell, AS Luksik, T Garzon-Muvdi, AL Hung, ES Kim, A Wu, Y Xia, ... Oncoimmunology 7 (12), e1500108, 2018 | 67 | 2018 |
| A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma C Jackson, J Choi, AM Khalafallah, C Price, C Bettegowda, M Lim, ... Journal of neuro-oncology 148, 419-431, 2020 | 63 | 2020 |
| The use of ribavirin as an anticancer therapeutic: will it go viral? J Casaos, NL Gorelick, S Huq, J Choi, Y Xia, R Serra, R Felder, T Lott, ... Molecular cancer therapeutics 18 (7), 1185-1194, 2019 | 54 | 2019 |
| Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, ... Oncogene 36 (21), 3037-3047, 2017 | 52 | 2017 |
| Nonviral polymeric nanoparticles for gene therapy in pediatric CNS malignancies J Choi, Y Rui, J Kim, N Gorelick, DR Wilson, K Kozielski, A Mangraviti, ... Nanomedicine: Nanotechnology, Biology and Medicine 23, 102115, 2020 | 48 | 2020 |
| Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste SJ Smith, BM Tyler, T Gould, GJ Veal, N Gorelick, J Rowlinson, R Serra, ... Clinical Cancer Research 25 (16), 5094-5106, 2019 | 46 | 2019 |
| Combination immunotherapy strategies for glioblastoma HY Chan, J Choi, C Jackson, M Lim Journal of neuro-oncology 151, 375-391, 2021 | 43 | 2021 |
| Regulatory T cells engineered with TCR signaling–responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter SK Eskandari, I Sulkaj, MB Melo, N Li, H Allos, JB Alhaddad, B Kollar, ... Science translational medicine 12 (569), eaaw4744, 2020 | 40 | 2020 |
| Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy Z Belcaid, C Berrevoets, J Choi, E Van Beelen, E Stavrakaki, T Pierson, ... Neuro-Oncology Advances 2 (1), vdaa011, 2020 | 34 | 2020 |
| It takes two: potential therapies and insights involving microglia and macrophages in glioblastoma J Choi, N Mai, C Jackson, Z Belcaid, M Lim population 10 (11), 10.20517, 2018 | 25 | 2018 |
| Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma J Choi, R Medikonda, L Saleh, T Kim, A Pant, S Srivastava, YH Kim, ... Oncoimmunology 10 (1), 1956142, 2021 | 22 | 2021 |
| In vivo bioluminescence tomography center of mass-guided conformal irradiation Z Deng, X Xu, T Garzon-Muvdi, Y Xia, E Kim, Z Belcaid, A Luksik, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 612-620, 2020 | 21 | 2020 |
| CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma L Tong, J Li, J Choi, A Pant, Y Xia, C Jackson, P Liu, L Yi, E Boussouf, ... Cancer Gene Therapy 27 (9), 669-679, 2020 | 18 | 2020 |
| Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors J Casaos, S Huq, T Lott, R Felder, J Choi, N Gorelick, M Peters, Y Xia, ... Oncotarget 9 (8), 8054, 2018 | 18 | 2018 |
| Regulatory T cells for more targeted immunosuppressive therapies H Allos, BS Al Dulaijan, J Choi, J Azzi Clinics in laboratory medicine 39 (1), 1-13, 2019 | 17 | 2019 |
| Absence of ischemic injury after sacrificing the superior petrosal vein during microvascular decompression Y Xia, TY Kim, LA Mashouf, KK Patel, R Xu, J Casaos, J Choi, ES Kim, ... Operative Neurosurgery 18 (3), 316-320, 2020 | 15 | 2020 |
